Top Markets
Coin of the day
Liminatus Pharma, Inc. Class A Common Stock Liminatus Pharma, Inc. Class A Common Stock

Liminatus Pharma, Inc. Class A Common Stock

LIMN
Rank in Stocks #32668
Liminatus Pharma, Inc. is an immuno-oncology firm, currently in its clinical... Liminatus Pharma, Inc. is an immuno-oncology firm, currently in its clinical development phase, dedicated to pioneering new treatments for cancer. The company's headquarters are located in La Palma, California.
Share Price
$0.1407
Last synced: 2026-08-17
Market Cap
$9.45M
Change (1 day)
0.50%
Change (1 year)
-96.46%
Country
US
Trade Liminatus Pharma, Inc. Class A Common Stock (LIMN)

Category

Price of LIMN with the market cap of B
Liminatus Pharma, Inc. Class A Common Stock Liminatus Pharma, Inc. Class A Common Stock
LIMN
$0.1407
Market Capitalization of Liminatus Pharma, Inc. Class A Common Stock(LIMN)
Market Cap: $9.45M
As of August 2026 Liminatus Pharma, Inc. Class A Common Stock has a market cap of $9.45M. This makes Liminatus Pharma, Inc. Class A Common Stock the world's 32668th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Liminatus Pharma, Inc. Class A Common Stock from 2025 to 2026
LIMN compared with Top 5 Most Popular stocks
Price of LIMN Asset B Mkt. of B Results
Liminatus Pharma, Inc. Class A Common Stock Liminatus Pharma, Inc. Class A Common Stock
$81,300.04 $9.45M
$5.460T +57,782,441.62%
Liminatus Pharma, Inc. Class A Common Stock Liminatus Pharma, Inc. Class A Common Stock
$66,847.23 $9.45M
$4.489T +47,510,368.48%
Liminatus Pharma, Inc. Class A Common Stock Liminatus Pharma, Inc. Class A Common Stock
$61,656.77 $9.45M
$4.141T +43,821,345.78%
Liminatus Pharma, Inc. Class A Common Stock Liminatus Pharma, Inc. Class A Common Stock
$53,134.52 $9.45M
$3.569T +37,764,308.49%
Liminatus Pharma, Inc. Class A Common Stock Liminatus Pharma, Inc. Class A Common Stock
$41,661.91 $9.45M
$2.798T +29,610,358.30%